explore -WSS

explore

author：explore 2025-09-28 18:47:39 - browse：25258

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.

For more on what we cover, here’s more on PIPEs; here’s the news from Viking Therapeutics; here’s the latest in MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： ALS groups 'won't be played again' by the FDA, drug sponsors

hotspot

WSS

Why getting cancer drugs just got harder for rural patients

How to fix the rural physician shortage in the U.S.

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Data don't support strong claims for Covid

Anthony Fauci pushes back on GOP claims during Covid hearing

entertainment

explore

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

Congress needs to close a vaccine

Medicare details structure of new drug price negotiation program

Clinical trials giant ICON acquires HumanFirst

Psychedelics group wrestles with new pharma identity

Scientists unlock the key to scar

How to save PrEP access — and even expand it

Why getting cancer drugs just got harder for rural patients

In age of alternative facts, a scholarly course on calling out crap

An inside look at PIPEs, biotech's buzzy new financing tool

hotspot

Medical device lobby: We're tired of waiting on Medicare coverage

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

UnitedHealth CEO's Medicaid comments send insurer stocks diving

FogPharma raises $145 million in rare Series E round

RSV vaccines may be linked to small increased risk of developing GBS

Congress needs to close a vaccine

leisure time

hotspot

knowledge

focus